Number of the records: 1  

The chemical profile and pharmacodynamic properties of extracellular Wollea saccata biopolymer

  1. 1.
    0478834 - MBÚ 2018 RIV NL eng J - Journal Article
    Šutovská, M. - Kočmálová, M. - Pappová, L. - Fraňová, S. - Chyba, A. - Kopecký, Jiří - Lukavský, Jaromír - Cepák, Vladislav - Capek, P.
    The chemical profile and pharmacodynamic properties of extracellular Wollea saccata biopolymer.
    International Journal of Biological Macromolecules. Roč. 103, OCT 2017 (2017), s. 863-869. ISSN 0141-8130. E-ISSN 1879-0003
    R&D Projects: GA TA ČR TE01020080
    Institutional support: RVO:61388971 ; RVO:67985939
    Keywords : Wollea saccata * Extracellular proteoglycan * Pharmacodynamic properties
    OECD category: Microbiology; Bioproducts (products that are manufactured using biological material as feedstock) biomaterials, bioplastics, biofuels, bioderived bulk and fine chemicals, bio-derived novel materials (BU-J)
    Impact factor: 3.909, year: 2017

    Microalgae organisms are of interest for many biotechnology applications due to the production of a wide range of biologically active compounds. Incubation of Wollea saccata in a large scale afforded a mucilaginous, high molecular weight biopolymer composed of carbohydrate, protein and phenolic compounds. Sugar moiety was rich in hexoses (60%) and 6-deoxyhexoses (31%), while only 9% of pentoses was identified. Methylation analysis revealed about 40 types of methylated sugar derivatives, suggesting a very complex structure of Wollea biopolymer. Pharmacological studies revealed new pharmacodynamic properties of cyanobacteria biopolymer, i.e. antitussive and bronchodilatory. Biopolymer was able to suppress the cough reflex induced by chemical tussigen, but its effect was lower than that of codeine, the strongest antitussive agent. The bronchodilatory effect was similar or higher than the effect of salbutamol, a bronchodilatory drug used in a clinical practice. In pharmacological studies, there were no signs of toxicity or side effects in the animals following administration of Wollea biopolymer.
    Permanent Link: http://hdl.handle.net/11104/0274884

     
     
Number of the records: 1  

  This site uses cookies to make them easier to browse. Learn more about how we use cookies.